Colfosceril Palmitate
Generic medicine reference
Not yet clinically reviewed
This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.
Overview
Colfosceril Palmitate is a phospholipid which forms an important constituent of endogenous pulmonary surfactant compounds.
Indications
Colfosceril Palmitate is primarily indicated in conditions like Respiratory distress syndrome.
Contraindications
Colfosceril Palmitate is contraindicated in conditions like Hypersensitivity to any component of product.
Side Effects
The symptomatic adverse reactions produced by Colfosceril Palmitate are more or less tolerable and if they become severe, they can be treated symptomatically, these include Pulmonary hemorrhage, Obstruction of the endotracheal tube by mucous secretions.
Warnings
Continuous monitoring is required to avoid hypoxemia (due to rapid improvement in arterial oxygen concentration)
High Risk Groups
Drug should not be given to Neonates. If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Adult Dosage
5 ml/kg (5 (5)) As recommended. IV — Prophylactic treatment: 1st dose should be given after birth and 2nd and 3rd dose is given 12 and 24 hours later to infants.
Child Dosage
No child dosage information is recorded for this medicine yet.
Neonatal Dosage
No neonatal dosage information is recorded for this medicine yet.
Drug Interactions
No data regarding the interactions of Colfosceril Palmitate was found.
Storage
Store Below 40°C. Freezing is recommended.
Available Brands in Pakistan
No active brands are currently recorded for this generic.
1 record is present but flagged "Unverified / Legacy" and excluded.